Conversion From Cyclosporine to Mycophenolate Mofetil Improves Expression of A20 in the Rat Kidney Allografts Undergoing Chronic Rejection

Transplantation Proceedings

Volumn 38, Issue 7, 2006, Pages 2164-2167

  Teng, D ^a   Lu, Y ^a   Gao, R ^a   Xin, Y ^a   Cao, G ^a   Li, X ^a   Wang, L ^a   Wang, J ^a   Li, Y ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; HEME OXYGENASE 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN A20; PROTEIN BCL 2; PROTEIN BCL XL; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTERIOSCLEROSIS; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; DRUG SUBSTITUTION; ENDOTHELIUM; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; STATISTICAL ANALYSIS;

ANIMALS; BCL-X PROTEIN; CHRONIC DISEASE; CYCLOSPORINE; DISEASE MODELS, ANIMAL; DNA PRIMERS; GENE EXPRESSION REGULATION; GRAFT REJECTION; HEME OXYGENASE-1; KIDNEY TRANSPLANTATION; MALE; MYCOPHENOLIC ACID; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846056988     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.06.007     Document Type: Article

References (10)

1. Allison A.C., and Eugui E.M. Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection. Transplantation 80 (2005) S181
2. Ojo A.O., Meier-Kriesche H.-U., Hanson J.A., et al. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation 69 (2000) 2405
3. Kunter U., Floege J., Jurgensonn A.S., et al. Expression of A20 in the vessel wall of rat-kidney allografts correlates with protection from transplant arteriosclerosis. Transplantation 75 (2003) 3
4. Bach F.H., Ferran C., Hechenleitner P., et al. Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med 3 (1997) 196
5. Badrichani A., Stroka D.M., Bilbao G., et al. Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-κB. J Clin Invest 103 (1999) 543
6. Brouard S., Otterbein L.E., Anrather J., et al. Carbon monoxide generated by heme oxygenase-1 suppresses endothelial cell apoptosis. J Exp Med 192 (2000) 1015
7. Opipari A.J., Hu H.M., Yabkowitz R., et al. The A20 zinc finger protein protects cells from TNF cytotoxicity. J Biol Chem 267 (1992) 12424
8. Ferran C., Stroka D.M., Badrichani A.Z., et al. A20 inhibits NF-κB activation in endothelial cells without sensitizing to TNF-mediated apoptosis. Blood 91 (1998) 2249
9. Lee E.G., Boone D.L., Chai S., et al. Failure to regulate TNF-induced NF-kappa B and cell death responses in A20-deficient mice. Science 289 (2000) 2350
10. Arvelo M.B., Badrichani A.Z., Stroka D.M., et al. A novel function for A20 in smooth muscle cells: inhibition of activation and proliferation. Transplant Proc 31 (1999) 858